Text Size
19 studies found for:    Open Studies | "Duodenal Ulcer"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal Ulcer
Condition: Duodenal Ulcer
Interventions: Drug: TAK-438;   Drug: Placebo;   Drug: Lansoprazole
2 Recruiting A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy
Conditions: Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: TAK-438
3 Recruiting A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy
Conditions: Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: TAK-438
4 Recruiting Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)
Condition: Gastric or Duodenal Ulcers Caused by Low-dose Aspirin
Interventions: Drug: E3810;   Drug: Teprenone
5 Recruiting Long-term Prevention of Recurrent Gastric or Duodenal Ulcers Caused by Low-dose Aspirin With Rabeprazole (E3810) Treatment (Planetarium Study)
Condition: Gastric Ulcers Duodenal Ulcers Caused by Low-dose Aspirin
Intervention: Drug: E3810
6 Recruiting Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation
Conditions: Gastric Ulcer;   Duodenal Ulcer
Intervention:
7 Recruiting Nexium Capsules LDA Specific Clinical Experience Investigation
Conditions: Gastric Ulcer;   Duodenal Ulcer
Intervention:
8 Recruiting Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin
Conditions: Gastric Ulcers;   Duodenal Ulcers
Interventions: Drug: TAK-438;   Drug: Placebo;   Drug: Lansoprazole
9 Recruiting Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin
Conditions: Gastric Ulcers;   Duodenal Ulcers
Interventions: Drug: TAK-438;   Drug: Placebo;   Drug: Lansoprazole
10 Recruiting Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)
Conditions: Gastric Ulcers;   Duodenal Ulcers
Interventions: Drug: TAK-438;   Drug: Placebo;   Drug: Lansoprazole
11 Recruiting Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)
Conditions: Gastric Ulcers;   Duodenal Ulcers
Interventions: Drug: TAK-438;   Drug: Placebo;   Drug: Lansoprazole
12 Unknown † Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: rabeprazole, amoxicillin, clarithromycin, metronidazole
13 Recruiting Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation
Conditions: Gastric Ulcer;   Duodenal Ulcer;   Gastric Mucosa-associated Lymphoid Tissue (MALT);   Lymphoma Idiopathic Thrombocytopenic Purpura;   Early Gastric Cancer
Intervention:
14 Unknown † Cytokine Gene Polymorphisms in Gastric Diseases
Conditions: Gastric Ulcer;   Duodenal Ulcer;   Gastric Cancer
Intervention: Procedure: IL-1, TNF-alpha, Il-10
15 Unknown † Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori
Conditions: Helicobacter Infections;   Gastritis;   Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: Lansoprazole, clarithromycin, amoxicillin
16 Unknown † Comparison of Ulcer Healing in Patients Taking Rabeprazole With Different Antiplatelets
Conditions: Gastric Ulcer;   Duodenal Ulcer
Intervention: Drug: rabeprazole plus aspirin versus rabeprazole plus clopidogrel
17 Recruiting Nexium Capsules Clinical Experience Investigation
Condition: Gastric Ulcer, Duodenal Ulcer, Anastomotic Ulcer, Reflux Oesophagitis,"Non-erosive Reflux Disease, Zollinger-Ellison Syndrome
Intervention:
18 Not yet recruiting Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting Conditions
Condition: Ulcers, Duodenal and Gastric
Interventions: Drug: Test 1= ASA 100 mg and pantoprazole 20 mg capsule formulation one;   Drug: Test 2= ASA 100 mg and pantoprazole 20 mg capsule formulation two;   Drug: ASA 100 mg tablet;   Drug: Pantoprazole 20 mg gastro-resistant tablet
19 Not yet recruiting Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fed Conditions
Condition: Ulcers, Duodenal and Gastric
Interventions: Drug: Test 1= ASA 100 mg and pantoprazole 20 mg capsule formulation one;   Drug: Test 2= ASA 100 mg and pantoprazole 20 mg capsule formulation two;   Drug: ASA 100 mg tablet;   Drug: Pantoprazole 20 mg gastro-resistant tablet
To Top

† Indicates status has not been verified in more than two years